" Mesoblast Limited
(ASX:MSB; Nasdaq:MESO), global leader in allogeneic cellular medicines for inflammatory diseases,
today announced that Philip R. Krause, M.D. has joined its Board of Directors. Dr. Krause was for the
past decade Deputy Director, Office of Vaccines Research and Review (OVRR) at the US Food and
Drug Administration (FDA)’s Center for Biologics Evaluation and Research (CBER). Dr. Krause is
currently Chair of the World Health Organization COVID Vaccines Research Expert Group, and most
recently he shared responsibility for regulatory authorizations of COVID-19 vaccines in the US."
Pretty cool though
Ann: Director Appointment, page-3
-
- There are more pages in this discussion • 211 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.035(3.21%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.07 | $3.910M | 3.535M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27197 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 43578 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |